XPH(300147)

Search documents
中药板块9月30日跌0.28%,ST香雪领跌,主力资金净流出4.78亿元
Zheng Xing Xing Ye Ri Bao· 2025-09-30 08:42
证券之星消息,9月30日中药板块较上一交易日下跌0.28%,ST香雪领跌。当日上证指数报收于3882.78, 上涨0.52%。深证成指报收于13526.51,上涨0.35%。中药板块个股涨跌见下表: | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 002390 | 信邦制药 | 3.80 | 10.14% | 97.44万 | 3.61亿 | | 002082 | 万邦德 | 66"II | 10.00% | 21.66万 | 2.52亿 | | 600080 | 金花股份 | 7.42 | 2.91% | 10.23万 | 7530.92万 | | 002317 | 众生药业 | 17.28 | 1.83% | 27.45万 | 4.73亿 | | 002728 | 特一药业 | 8.61 | 1.06% | 5.04万 | 4327.67万 | | 600535 | 天士力 | 15.80 | 1.02% | 15.03万 | 2.37亿 | | 002907 | 华森制药 | 16.32 ...
ST香雪(300147) - 第九届董事会第三十次会议决议公告
2025-09-30 07:56
证券代码:300147 证券简称:ST 香雪 公告编号:2025-045 广州市香雪制药股份有限公司 第九届董事会第三十次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假 记载、误导性陈述或重大遗漏。 表决结果:同意 6 票、反对 0 票、弃权 0 票。 特此公告。 广州市香雪制药股份有限公司董事会 2025 年 9 月 30 日 审议通过了《关于聘任董事会秘书的议案》 公司董事会于近日收到公司董事、董事会秘书徐力先生的书面辞职报告,徐 力先生因个人原因,申请辞去公司董事会秘书职务,辞去上述职务后,徐力先生 仍在公司担任董事职务。 根据《公司法》《深圳证券交易所上市公司自律监管指引第 2 号——创业板 上市公司规范运作》及《公司章程》的相关规定,公司董事会同意聘任向进先生 担任公司董事会秘书,任期自本次董事会审议通过之日起至第九届董事会届满之 日止(目前公司第九届董事会已届满,换届选举工作尚在筹备中,为保证公司董 事会工作的连续性和稳定性,公司第九届董事会将延期换届,本届董事会各专门 委员会、高级管理人员的任期也将相应顺延)。 本议案已经公司董事会提名委员会审议通过。 具体内容 ...
ST香雪(300147) - 关于董事会秘书离任及聘任董事会秘书的公告
2025-09-30 07:56
一、关于董事会秘书离任的情况 广州市香雪制药股份有限公司(以下简称"公司")董事会于近日收到公司 董事、董事会秘书徐力先生的书面辞职报告,徐力先生因个人原因,申请辞去公 司董事会秘书职务,根据《公司法》《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》《公司章程》等相关规定,徐力先生的辞职 申请自送达董事会之日起生效。辞去上述职务后,徐力先生仍在公司担任董事职 务。 截至本公告披露日,徐力先生持有公司 201,701 股,占公司总股本 0.03%, 不存在应当履行而未履行的承诺事项,其辞去董事会秘书职务后仍将严格按照 《上市公司董事、监事和高级管理人员所持本公司股份及其变动管理规则》《深 圳证券交易所上市公司自律监管指引第 18 号——股东及董事、高级管理人员减 持股份(2025 年修订)》等相应法律、法规、规范性文件进行管理。 公司及董事会对徐力先生在任职期间为公司发展作出的贡献表示衷心的感 谢。 证券代码:300147 证券简称: ST 香雪 公告编号:2025-046 广州市香雪制药股份有限公司 关于董事会秘书离任及聘任董事会秘书的公告 本公司及董事会全体成员保证信息披露的内容真 ...
香雪制药董事长王永辉:大数据、人工智能给中医带来前所未有的机会
Feng Huang Wang Cai Jing· 2025-09-24 09:30
广州市香雪制药股份有限公司董事长 王永辉 广州市香雪制药股份有限公司董事长王永辉在主旨演讲中深入阐释了人工智能与大数据技术如何为中医发展带来革命性机遇,并推动其科学化、国际化进 程。 他指出,中医本质上是一门数据科学,但传统依赖名医个人经验的模式存在数据量不足、效果不稳定等局限,导致其难以经受科学验证。中医传承长期受限 于人的接触空间、人的寿命和人的经验,"一代人可能只有一代名师",而如今大数据与人工智能恰好能够弥补这一短板。 在王永辉看来,中医是人工智能理想的应用场景,技术革新为中医的个性化诊疗优势提供了强大支撑。同时,大模型更符合中医的辩证逻辑,在知识处理方 面,从海量数据到整体模型,推理的方式为非线性关联的涌现。它不一定是一个纯粹的数据逻辑关系,它输出的结果为动态、个性化的模糊正确。他指出中 医和大模型二者均具有"黑箱现象":不一定能说清楚为什么是这样,但结论就是正确的。 他总结道,通过AI赋能,中医正在突破经验"黑箱"的限制,实现诊断与治疗闭环的精准化和智能化,最终实现"疗效"的显著提升和持续进化。他相信,随着 疗效不断提升,中医将赢得世界的广泛认同,在人类健康事业上大放异彩。 凤凰网财经讯 9月23 ...
香雪制药董事长王永辉:中医是为人而设的医学,它属于中国,更属于世界
Feng Huang Wang Cai Jing· 2025-09-24 09:30
广州市香雪制药股份有限公司董事长 王永辉 在主旨演讲环节,广州市香雪制药股份有限公司董事长王永辉以"风雨兼程是常态,风雨无阻是心态,风调雨顺是理想状态",精准勾勒了中国企业在全球化 进程中的精神面貌与追求。 王永辉特别聚焦中医国际化。他表示,当前中国生物医药出海已呈现"井喷"态势,今年出海规模超过800亿美元,且实现了从简单的产品输出到知识产权的 出海。他同时强调,中医代表着中国文化,代表中国独有的医疗资源、药材资源和生物资源,中医出海正迎来历史机遇。 王永辉通过一系列国际现象展示中医的全球影响力,他表示,"中医是为人而设的医学,它一定是属于中国,更属于世界,因为它是全人类共享的财富。"尽 管如此,他直言中医在实际医学应用中的占比仍然很小,"真正的出海,真正的为世界所接受,距离还是很远"。 凤凰网财经讯 9月23-24日,由凤凰卫视、凤凰网主办的"凤凰湾区财经论坛2025"在广州举行,本届论坛以"新格局·新路径"为主题,汇聚全球政商学界精 英,共同洞察变局脉络、探寻发展新机。 ...
短线防风险 127只个股短期均线现死叉
Zheng Quan Shi Bao Wang· 2025-09-17 04:23
Market Overview - The Shanghai Composite Index closed at 3877.55 points, with a change of 0.41% [1] - The total trading volume of A-shares reached 1561.918 billion yuan [1] Technical Analysis - A total of 127 A-shares experienced a death cross, where the 5-day moving average fell below the 10-day moving average [1] - Notable stocks with significant distance between their 5-day and 10-day moving averages include: - COFCO Technology: 5-day MA at 11.41 yuan, 10-day MA at 11.52 yuan, difference of -0.92% [1] - Jiuri New Materials: 5-day MA at 27.35 yuan, 10-day MA at 27.59 yuan, difference of -0.86% [1] - Potential Energy Trust: 5-day MA at 20.44 yuan, 10-day MA at 20.59 yuan, difference of -0.77% [1] Individual Stock Performance - COFCO Technology: Today's change of 0.09%, trading volume of 1.13% [1] - Jiuri New Materials: Today's change of 1.49%, trading volume of 1.84% [1] - Potential Energy Trust: Today's change of 0.34%, trading volume of 1.64% [1] - Other notable stocks with death crosses include: - Tongzhou Electronics: Today's change of -0.42%, trading volume of 2.40% [1] - ST Long Pharmaceutical: Today's change of -2.50%, trading volume of 2.14% [1] - Jin Hong Shun: Today's change of -1.44%, trading volume of 2.07% [1]
ST香雪(300147) - 关于参加广东辖区2025年投资者网上集体接待日活动的公告
2025-09-16 07:48
为进一步加强与投资者的互动交流,广州市香雪制药股份有限公司(以下简 称"公司")将参加由中国证券监督管理委员会广东监管局、广东上市公司协会 联合举办的"向新提质 价值领航--2025 年广东上市公司投资者关系管理月投资 者集体接待日活动",现将相关事项公告如下: 本次活动将采用网络远程的方式举行,投资者可登录"全景路演"网站 (http://rs.p5w.net)参与本次互动交流,活动时间为 2025 年 9 月 19 日(周 五)15:30-17:00。 届时公司高管将在线就 2025 年半年度业绩、公司治理、发展战略、经营状 况和可持续发展等投资者关心的问题,与投资者进行沟通与交流,欢迎广大投资 者踊跃参与! 广州市香雪制药股份有限公司 关于参加广东辖区 2025 年投资者网上集体接待日活动的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假 记载、误导性陈述或重大遗漏。 证券代码:300147 证券简称: ST 香雪 公告编号:2025-044 特此公告。 广州市香雪制药股份有限公司董事会 2025 年 9 月 16 日 ...
中药板块9月15日跌0.37%,ST香雪领跌,主力资金净流出4.7亿元
Zheng Xing Xing Ye Ri Bao· 2025-09-15 08:42
Market Overview - The Chinese medicine sector experienced a decline of 0.37% on September 15, with ST Xiangxue leading the drop [1] - The Shanghai Composite Index closed at 3860.5, down 0.26%, while the Shenzhen Component Index rose by 0.63% to 13005.77 [1] Stock Performance - Notable gainers in the Chinese medicine sector included: - Wanbangde (002082) with a closing price of 11.33, up 10.00% [1] - Kangmei Pharmaceutical (600518) at 2.18, up 4.81% [1] - Zhongheng Group (600252) at 2.88, up 3.97% [1] - Conversely, ST Xiangxue (300147) saw a significant decline of 4.39%, closing at 10.66 [2] - Other notable decliners included: - Enwei Pharmaceutical (301331) down 3.25% [2] - Zhendong Pharmaceutical (300158) down 2.97% [2] Trading Volume and Capital Flow - The Chinese medicine sector recorded a net outflow of 470 million yuan from institutional investors, while retail investors saw a net inflow of 398 million yuan [2] - The trading volume for major stocks included: - Kangmei Pharmaceutical with a trading volume of 9.5463 million shares and a transaction value of 2.086 billion yuan [1] - Wanbangde with a trading volume of 414,700 shares and a transaction value of 448 million yuan [1] Capital Inflow Analysis - Major stocks with significant net inflows from institutional investors included: - Kangmei Pharmaceutical with a net inflow of 18.7 million yuan [3] - Wanbangde with a net inflow of 67.5 million yuan [3] - Conversely, stocks like Zhongheng Group and Panzhong Pharmaceutical experienced net outflows from institutional investors [3]
中药板块9月5日涨0.99%,ST香雪领涨,主力资金净流入5544.01万元
Zheng Xing Xing Ye Ri Bao· 2025-09-05 08:56
Group 1 - The traditional Chinese medicine sector saw an increase of 0.99% on September 5, with ST Xiangxue leading the gains [1] - The Shanghai Composite Index closed at 3812.51, up 1.24%, while the Shenzhen Component Index closed at 12590.56, up 3.89% [1] - Key stocks in the traditional Chinese medicine sector included ST Xiangxue, which rose by 10.41% to a closing price of 11.24, and Daren Tang, which increased by 3.89% to 45.91 [1] Group 2 - The traditional Chinese medicine sector experienced a net inflow of 55.44 million yuan from institutional investors, while retail investors saw a net outflow of 151 million yuan [2] - Major stocks with significant net inflows included Tian Shili with 54.05 million yuan and Jilin Aodong with 31.24 million yuan [3] - ST Xiangxue had a net inflow of 24.95 million yuan from institutional investors, despite a net outflow from retail investors [3]
外资全线加仓,两个板块是逃不掉的!
Sou Hu Cai Jing· 2025-09-01 14:53
Group 1 - Major financial institutions like JPMorgan, Citigroup, and Morgan Stanley have recently increased their holdings in H-shares such as CATL, ZTE, and WuXi AppTec, indicating a growing interest in these stocks [1] - JPMorgan's long position in CATL H-shares rose from 5.98% to 6.06%, while Morgan Stanley's increased from 4.96% to 6.05% [1] - The Hong Kong stock market showed strong performance in August, with the Hang Seng Index rising by 1.23% and the Hang Seng Tech Index increasing by 4.06% [3] Group 2 - There is a concern that retail investors often enter the market after institutions have already made their moves, leading to potential losses for these investors [5] - A notable example of institutional behavior is highlighted, where foreign institutions claimed to avoid thematic stocks but were found heavily invested in restructuring concept stocks after earnings reports were released [6] - The concept of "institutional inventory" is introduced as a key indicator of institutional trading activity, suggesting that active participation by institutions can signal future stock performance [9][11] Group 3 - The article emphasizes the importance of understanding the true flow of funds rather than relying on news, which often lags behind actual market movements [14] - It is suggested that retail investors should focus on analyzing data that reveals institutional actions to avoid being misled by superficial news [14] - The conclusion stresses that those who can access and interpret real data will have a competitive advantage in the market [14]